K.P. Bouter

1.5k citations

22 papers · 1.1k indexed · h-index 16

Impact in

Endocrinology, Diabetes and Metabolism top 5%
- Diabetes Management and Research
- Diabetes Treatment and Management
Urology top 5%
- Urinary Bladder and Prostate Research

Papers in

Applied Microbiology and Biotechnology 1
Endocrinology, Diabetes and Metabolism 6
- Diabetes Management and Research 3
- Diabetic Foot Ulcer Assessment and Management 2

Co-authors: R.J.A. Diepersloot Frank L.J. Visseren J. B. L. Hoekstra John J. M. Bouwman R. J. A. Diepersloot N. Masurel Suzanne E. Geerlings A R Jansz
Journals: European Journal of Clinical Investigation (4 papers)International Journal of Antimicrobial Agents (2 papers)Diabetes Care (2 papers)Diabetic Medicine (2 papers)Diabetes Research and Clinical Practice (2 papers)
Partner nations: Netherlands Germany Italy

In The Last Decade

K.P. Bouter

21 papers receiving 1.1k citations

Peers

Countries citing papers authored by K.P. Bouter

Since Specialization

Citations

This map shows the geographic impact of K.P. Bouter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K.P. Bouter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K.P. Bouter more than expected).

Fields of papers citing papers by K.P. Bouter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K.P. Bouter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K.P. Bouter. The network helps show where K.P. Bouter may publish in the future.

Co-authorship network

The 25 scholars most cited alongside K.P. Bouter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with K.P. Bouter Line = papers co-authored together K.P. Bouter links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Infection-induced inflammatory response of adipocytes in vitro International Journal of Obesity ·John J. M. Bouwman, Frank L.J. Visseren, K.P. Bouter, R.J.A. Diepersloot	2008	49
2	Infection induced inflammation is associated with erectile dysfunction in men with diabetes European Journal of Clinical Investigation ·菅原眞一, Frank L.J. Visseren, Jan Dirk Banga, J. B. L. Hoekstra, Y. van der Graaf, R. J. A. Diepersloot, K.P. Bouter	2006	22
3	Azithromycin reduces Chlamydia pneumoniae‐induced attenuation of eNOS and cGMP production by endothelial cells European Journal of Clinical Investigation ·John J. M. Bouwman, Frank L.J. Visseren, Michel K. GOMGNIMBOU, Janelyn A. Ambre, K.P. Bouter, R.J.A. Diepersloot	2005	10
4	Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH‐based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5‐nations trial Diabetic Medicine ·Roel P.L.M. Hoogma, Peter Hammond, Ramón Gomis, David Kerr, Daniela Bruttomesso, K.P. Bouter, K. Wiefels, Hermenegildo de la Calle, Dave H. Schweitzer, Martin Pfohl, Elisabetta Torlone, Lars Krinelke, Geremia B. Bolli, (unknown)	2005	189
5	Cytomegalovirus and Chlamydia pneumoniae as predictors for adverse events and angina pectoris after percutaneous coronary intervention American Heart Journal ·Braim M. Rahel, Frank L.J. Visseren, Maarten-Jan Suttorp, K. Patten, Johannes C. Kelder, Bartelt M. de Jongh, R.J.A. Diepersloot, R P Verkooyen, K.P. Bouter	2004	5
6	Acute‐phase response of human hepatocytes after infection with Chlamydia pneumoniae and cytomegalovirus European Journal of Clinical Investigation ·Aji Adhi Nugraha, Frank L.J. Visseren, K.P. Bouter, R. J. A. Diepersloot	2003	8
7	Procoagulant and inflammatory response of virus‐infected monocytes European Journal of Clinical Investigation ·John J. M. Bouwman, Frank L.J. Visseren, Anne-Cecile Tregaro, K.P. Bouter, R. J. A. Diepersloot	2002	58
8	Procoagulant Activity of Endothelial Cells after Infection with Respiratory Viruses Thrombosis and Haemostasis ·John J. M. Bouwman, K.P. Bouter, R.J.A. Diepersloot, (unknown), D.W. Erkelens, Frank L.J. Visseren	2000	103
9	Asymptomatic bacteriuria may be considered a complication in women with diabetes. Diabetes Mellitus Women Asymptomatic Bacteriuria Utrecht Study Group. Diabetes Care ·Suzanne E. Geerlings, Ronald P. Stolk, Diego Ibanez, Vania Teresa Martínez Jiménez, Luke Busse, K.P. Bouter, Bert Bravenboer, Steven F Hick, A R Jansz, Andy I. M. Hoepelman	2000	186
10	Interleukin-6 production by endothelial cells after infection with influenza virus and cytomegalovirus Journal of Laboratory and Clinical Medicine ·Frank L.J. Visseren, Aji Adhi Nugraha, K.P. Bouter, R.J.A. Diepersloot, D.W. Erkelens	1999	37
11	Tissue Concentrations after a Single-Dose, Orally Administered Ofloxacin in Patients with Diabetic Foot Infections Foot & Ankle International ·和泉宏幸, K.P. Bouter, J. B. L. Hoekstra, Irvan Taslim, R.J.A. Diepersloot	1998	26
12	Patients with diabetes mellitus and atherosclerosis; a role for cytomegalovirus? Diabetes Research and Clinical Practice ·Frank L.J. Visseren, K.P. Bouter, Mijndert-Jan Pon, J. B. L. Hoekstra, D.W. Erkelens, R.J.A. Diepersloot	1997	15
13	Treatment of diabetic foot infection: an open randomised comparison of imipenem/cilastatin and piperacillin/clindamycin combination therapy International Journal of Antimicrobial Agents ·K.P. Bouter, Frank L.J. Visseren, Xiqiang Tang, A. K. M. Bartelink, D. Willem Erkelens, R.J.A. Diepersloot	1996	12
14	A sequential study of intravenous and oral Fleroxacin for 7 or 14 days in the treatment of complicated urinary tract infections International Journal of Antimicrobial Agents ·神谷律, Bohdan Veresotskyi, K.P. Bouter, Evgenia Yu. Ziablitskaia, J. Verhoef, A. Springall, Tom A. Boon, I. M. Hoepelman	1995	25
15	Humoral Immune Response to a Yeast‐derived Hepatitis B Vaccine in Patients with Type 1 Diabetes Mellitus Diabetic Medicine ·K.P. Bouter, R.J.A. Diepersloot, Pieter J. Wismans, Frits H.J. Gmelig Meyling, J. B. L. Hoekstra, R. A. Heijtink, Jan van Hattum	1992	26
16	A prospective study of in vitro anti‐HBs producing B cells (spot‐ELISA) following primary and supplementary vaccination with a recombinant hepatitis B vaccine in insulin dependent diabetic patients and matched controls Journal of Medical Virology ·Pieter J. Wismans, Jan van Hattum, G C de Gast, K.P. Bouter, R. J. A. Diepersloot, Tjander Maikoe, Geert C. Mudde	1991	40
17	Effect of epidemic influenza on ketoacidosis, pneumonia and death in diabetes mellitus: a hospital register survey of 1976–1979 in The Netherlands Diabetes Research and Clinical Practice ·K.P. Bouter, R.J.A. Diepersloot, L. K. J. van Romunde, 裕明山永, N. Masurel, J. B. L. Hoekstra, D. Willem Erkelens	1991	57
18	Influenza Infection and Diabetes Mellitus: Case for Annual Vaccination Diabetes Care ·R.J.A. Diepersloot, K.P. Bouter, J. B. L. Hoekstra	1990	30
19	Once-daily dosing regimen for aminoglycoside plus β-Lactam combination therapy of serious bacterial infections: Comparative trial with netilmicin plus ceftriaxone The American Journal of Medicine ·E.W.M.T. ter Braak, Peter J. de Vries, K.P. Bouter, Zunhui Ge, Han Jian-guo, J.W.R. Nortier, Arie P.J. van Dijk, R P Verkooyen, Henri A. Verbrugh	1990	120
20	Humoral immune response and delayed type hypersensitivity to influenza vaccine in patients with diabetes mellitus Diabetologia ·R. J. A. Diepersloot, K.P. Bouter, W.E.P. Beyer, J. B. L. Hoekstra, N. Masurel	1987	66

About K.P. Bouter

K.P. Bouter is a scholar working on Applied Microbiology and Biotechnology, Endocrinology, Diabetes and Metabolism, Epidemiology, Immunology and Microbiology, having authored 22 papers that have together received 1.1k indexed citations. Recurring topics across this work include Diabetes and associated disorders (9 papers), Influenza Virus Research Studies (3 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers), Atherosclerosis and Cardiovascular Diseases (3 papers), Diabetes Management and Research (3 papers), Immune Response and Inflammation (3 papers), Cytomegalovirus and herpesvirus research (3 papers) and Diabetic Foot Ulcer Assessment and Management (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (310 citations), Urology (112 citations), Epidemiology (548 citations), Molecular Medicine (61 citations) and Applied Microbiology and Biotechnology (22 citations). K.P. Bouter has collaborated with scholars based in Netherlands, Germany and Italy. Frequent co-authors include R.J.A. Diepersloot, Frank L.J. Visseren, J. B. L. Hoekstra, John J. M. Bouwman, R. J. A. Diepersloot, N. Masurel, Suzanne E. Geerlings, A R Jansz, Ronald P. Stolk and Andy I. M. Hoepelman. Their work appears in journals such as European Journal of Clinical Investigation, International Journal of Antimicrobial Agents, Diabetes Care, Diabetic Medicine and Diabetes Research and Clinical Practice.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact